Australia leads way on global health action

Australia has led a successful push for worldwide action to tackle two key global health issues – cervical cancer and eye health.   The Morrison Government welcomes the recent adoption of two Australian-led resolutions by member states of the World Health Organization (WHO):   Cervical Cancer Prevention and Control: Accelerating the Elimination of Cervical Cancer…

HMAS Cerberus: A Century of Service

This week is a significant anniversary on the Mornington Peninsula, with HMAS Cerberus formally commissioned as part of the Australian Defence Force 100 years ago. The Royal Australian Navy’s premier training establishment and oldest commissioned base, HMAS Cerberus was formally commissioned on 1 September 1920. Affectionately known as the ‘Cradle of the Navy’, Cerberus currently…

Funding boost for covid-19 research

The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and – the ultimate – a vaccine in the fight against COVID-19. Our Government has allocated $10.4 million for 13 early stage biomedical projects through Biomedical Translation Bridge (BTB) program, which forms part of the landmark Medical Research Future Fund…

Transcript – Doorstop – Canberra

E&OE… Topics: $563.4m aged care support announcement; Coronavirus update; One worker one site in Victoria; University of Queensland research; Medicare levy; Data on aged care workers; Aged care commission facility visits; State borders; Victorian pathway out; Senate committee; 41 deaths in Victoria; Craig Kelly comments on Hydroxychloroquine; Treasurer’s comments on Victorian outbreak; Has Senator Colbeck…

New hope for Australian leukaemia and lymphoma patients with key treatment option listed on PBS

A key new cancer treatment has just become more accessible for Australians fighting specific forms of leukaemia and lymphoma, thanks to the Morrison Government’s listing of Calquence® on the Pharmaceutical Benefits Scheme (PBS). On September 1, Calquence® (acalabrutinib) will be listed on the PBS for the first time for the treatment of chronic lymphocytic leukaemia…